Cargando…

Merkel Cell Carcinoma in the Setting of Chronic Lymphocytic Leukemia and Diffuse Large B-Cell Lymphoma

Merkel cell carcinoma (MCC) is a rare, rapidly growing, and highly malignant cutaneous tumor that typically presents in elderly males as an erythematous or violaceous plaque or nodule in sun-exposed areas. Risk factors include long-term ultraviolet (UV) exposure, Merkel cell polyomavirus (MCV) infec...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkhouri, Samaa, Afify, Omar, Alkhouri, Faris, Boalbanat, Hashem, Patel, Pragnesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380460/
https://www.ncbi.nlm.nih.gov/pubmed/34434683
http://dx.doi.org/10.7759/cureus.17204
_version_ 1783741201210408960
author Alkhouri, Samaa
Afify, Omar
Alkhouri, Faris
Boalbanat, Hashem
Patel, Pragnesh
author_facet Alkhouri, Samaa
Afify, Omar
Alkhouri, Faris
Boalbanat, Hashem
Patel, Pragnesh
author_sort Alkhouri, Samaa
collection PubMed
description Merkel cell carcinoma (MCC) is a rare, rapidly growing, and highly malignant cutaneous tumor that typically presents in elderly males as an erythematous or violaceous plaque or nodule in sun-exposed areas. Risk factors include long-term ultraviolet (UV) exposure, Merkel cell polyomavirus (MCV) infection, immunosuppression, and lymphoproliferative disorders such as chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). Given the aggressive nature of this tumor, patients may present with nodal and distal metastasis. Locoregional disease can be managed with definitive radiotherapy or surgery with or without adjuvant radiotherapy, depending on the case. Disseminated disease, on the other hand, often requires a multidisciplinary tumor board consultation to individually tailor the treatment. Possible treatments include systemic therapy with chemotherapy or immunotherapy, radiotherapy, and surgery. Here we report a case of a patient with a medical history significant for chronic lymphocytic leukemia and diffuse large B-cell lymphoma who presented with a rapidly growing lesion that contained neighboring MCC and CLL/SLL on biopsy. Management included immunotherapy with pembrolizumab and radiotherapy to limit the tumor's growth and spread. To the best of our knowledge, the coexistence of all three malignancies in a person is rare and has not been reported previously. 
format Online
Article
Text
id pubmed-8380460
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-83804602021-08-24 Merkel Cell Carcinoma in the Setting of Chronic Lymphocytic Leukemia and Diffuse Large B-Cell Lymphoma Alkhouri, Samaa Afify, Omar Alkhouri, Faris Boalbanat, Hashem Patel, Pragnesh Cureus Dermatology Merkel cell carcinoma (MCC) is a rare, rapidly growing, and highly malignant cutaneous tumor that typically presents in elderly males as an erythematous or violaceous plaque or nodule in sun-exposed areas. Risk factors include long-term ultraviolet (UV) exposure, Merkel cell polyomavirus (MCV) infection, immunosuppression, and lymphoproliferative disorders such as chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). Given the aggressive nature of this tumor, patients may present with nodal and distal metastasis. Locoregional disease can be managed with definitive radiotherapy or surgery with or without adjuvant radiotherapy, depending on the case. Disseminated disease, on the other hand, often requires a multidisciplinary tumor board consultation to individually tailor the treatment. Possible treatments include systemic therapy with chemotherapy or immunotherapy, radiotherapy, and surgery. Here we report a case of a patient with a medical history significant for chronic lymphocytic leukemia and diffuse large B-cell lymphoma who presented with a rapidly growing lesion that contained neighboring MCC and CLL/SLL on biopsy. Management included immunotherapy with pembrolizumab and radiotherapy to limit the tumor's growth and spread. To the best of our knowledge, the coexistence of all three malignancies in a person is rare and has not been reported previously.  Cureus 2021-08-15 /pmc/articles/PMC8380460/ /pubmed/34434683 http://dx.doi.org/10.7759/cureus.17204 Text en Copyright © 2021, Alkhouri et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Dermatology
Alkhouri, Samaa
Afify, Omar
Alkhouri, Faris
Boalbanat, Hashem
Patel, Pragnesh
Merkel Cell Carcinoma in the Setting of Chronic Lymphocytic Leukemia and Diffuse Large B-Cell Lymphoma
title Merkel Cell Carcinoma in the Setting of Chronic Lymphocytic Leukemia and Diffuse Large B-Cell Lymphoma
title_full Merkel Cell Carcinoma in the Setting of Chronic Lymphocytic Leukemia and Diffuse Large B-Cell Lymphoma
title_fullStr Merkel Cell Carcinoma in the Setting of Chronic Lymphocytic Leukemia and Diffuse Large B-Cell Lymphoma
title_full_unstemmed Merkel Cell Carcinoma in the Setting of Chronic Lymphocytic Leukemia and Diffuse Large B-Cell Lymphoma
title_short Merkel Cell Carcinoma in the Setting of Chronic Lymphocytic Leukemia and Diffuse Large B-Cell Lymphoma
title_sort merkel cell carcinoma in the setting of chronic lymphocytic leukemia and diffuse large b-cell lymphoma
topic Dermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380460/
https://www.ncbi.nlm.nih.gov/pubmed/34434683
http://dx.doi.org/10.7759/cureus.17204
work_keys_str_mv AT alkhourisamaa merkelcellcarcinomainthesettingofchroniclymphocyticleukemiaanddiffuselargebcelllymphoma
AT afifyomar merkelcellcarcinomainthesettingofchroniclymphocyticleukemiaanddiffuselargebcelllymphoma
AT alkhourifaris merkelcellcarcinomainthesettingofchroniclymphocyticleukemiaanddiffuselargebcelllymphoma
AT boalbanathashem merkelcellcarcinomainthesettingofchroniclymphocyticleukemiaanddiffuselargebcelllymphoma
AT patelpragnesh merkelcellcarcinomainthesettingofchroniclymphocyticleukemiaanddiffuselargebcelllymphoma